A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis
Couban, Stephen, Benevolo, Giulia, Donnellan, William, Cultrera, Jennifer, Koschmieder, Steffen, Verstovsek, Srdan, Hooper, Gregory, Hertig, Christian, Tandon, Maneesh, Dimier, Natalie, Malhi, Vikram,Volume:
11
Language:
english
Journal:
Journal of Hematology & Oncology
DOI:
10.1186/s13045-018-0661-x
Date:
December, 2018
File:
PDF, 587 KB
english, 2018